DGS Capital Management LLC Sells 494 Shares of Unum Group (NYSE:UNM)

DGS Capital Management LLC lowered its position in Unum Group (NYSE:UNM) by 1.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 33,149 shares of the financial services provider’s stock after selling 494 shares during the period. Unum Group makes up approximately 0.6% of DGS Capital Management LLC’s investment portfolio, making the stock its 24th biggest holding. DGS Capital Management LLC’s holdings in Unum Group were worth $1,499,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of UNM. Silver Oak Securities Incorporated bought a new stake in shares of Unum Group during the 3rd quarter worth approximately $25,000. Contravisory Investment Management Inc. purchased a new stake in Unum Group in the fourth quarter worth $25,000. Bangor Savings Bank lifted its position in shares of Unum Group by 100.0% during the third quarter. Bangor Savings Bank now owns 664 shares of the financial services provider’s stock worth $33,000 after purchasing an additional 332 shares during the last quarter. Neo Ivy Capital Management purchased a new stake in shares of Unum Group during the third quarter valued at $36,000. Finally, Arlington Trust Co LLC bought a new position in shares of Unum Group in the third quarter worth about $38,000. Institutional investors own 86.57% of the company’s stock.

Unum Group Stock Up 0.1 %

UNM traded up $0.07 on Tuesday, hitting $50.02. The company had a trading volume of 408,905 shares, compared to its average volume of 1,429,921. The stock has a market capitalization of $9.60 billion, a price-to-earnings ratio of 7.72, a P/E/G ratio of 1.01 and a beta of 0.87. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.27 and a current ratio of 0.27. The stock has a fifty day moving average price of $50.77 and a 200-day moving average price of $47.53. Unum Group has a 12-month low of $39.71 and a 12-month high of $54.57.

Unum Group (NYSE:UNM) last issued its quarterly earnings data on Tuesday, January 30th. The financial services provider reported $1.79 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.86 by ($0.07). The firm had revenue of $3.15 billion during the quarter, compared to analysts’ expectations of $3.14 billion. Unum Group had a return on equity of 16.03% and a net margin of 10.36%. The firm’s quarterly revenue was up 4.7% on a year-over-year basis. During the same period in the previous year, the firm earned $1.43 EPS. Analysts predict that Unum Group will post 8.18 EPS for the current fiscal year.

Unum Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 17th. Stockholders of record on Friday, April 26th will be given a $0.365 dividend. The ex-dividend date of this dividend is Thursday, April 25th. This represents a $1.46 dividend on an annualized basis and a dividend yield of 2.92%. Unum Group’s payout ratio is 22.50%.

Analyst Ratings Changes

Several equities research analysts have issued reports on the stock. StockNews.com raised shares of Unum Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 31st. Wells Fargo & Company raised their price objective on Unum Group from $64.00 to $66.00 and gave the stock an “overweight” rating in a report on Thursday, April 11th. Morgan Stanley upped their target price on Unum Group from $50.00 to $52.00 and gave the stock an “equal weight” rating in a report on Monday. JPMorgan Chase & Co. raised their price target on Unum Group from $56.00 to $58.00 and gave the company an “overweight” rating in a research note on Tuesday, April 2nd. Finally, The Goldman Sachs Group upped their price objective on shares of Unum Group from $47.00 to $52.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 31st. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $56.38.

Insider Buying and Selling

In other Unum Group news, CEO Richard P. Mckenney sold 50,000 shares of the stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $49.15, for a total value of $2,457,500.00. Following the completion of the sale, the chief executive officer now directly owns 1,076,753 shares in the company, valued at $52,922,409.95. The transaction was disclosed in a document filed with the SEC, which is available at this link. In related news, CFO Steven Andrew Zabel sold 10,000 shares of the firm’s stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $51.06, for a total value of $510,600.00. Following the completion of the transaction, the chief financial officer now owns 122,246 shares in the company, valued at approximately $6,241,880.76. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Richard P. Mckenney sold 50,000 shares of the business’s stock in a transaction dated Friday, March 1st. The shares were sold at an average price of $49.15, for a total value of $2,457,500.00. Following the sale, the chief executive officer now owns 1,076,753 shares in the company, valued at approximately $52,922,409.95. The disclosure for this sale can be found here. Insiders have sold a total of 81,000 shares of company stock worth $4,018,100 in the last ninety days. 0.77% of the stock is owned by insiders.

Unum Group Company Profile

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.